Literature DB >> 7966634

Integrase mutants of human immunodeficiency virus type 1 with a specific defect in integration.

B Taddeo1, W A Haseltine, C M Farnet.   

Abstract

A previous genetic analysis of the human immunodeficiency virus type 1 integrase protein failed to identify single amino acid substitutions that only block the integration of viral DNA (C.-G. Shin, B. Taddeo, W.A. Haseltine, and C.M. Farnet, J. Virol. 68:1633-1642, 1994). Additional substitutions of amino acids that are highly conserved among retroviral integrases were constructed in human immunodeficiency virus type 1 and analyzed for their effects on viral protein synthesis and processing, virion morphology, and viral DNA synthesis and integration in an attempt to identify mutants with a specific defect in integration. Four single amino acid substitutions resulted in replication defective viruses. Conservative, single amino acid substitutions of the two invariant aspartic acid residues found in all retroviral integrases prevented the integration of viral DNA and had no detectable effect on the other stages in the viral replication cycle, indicating that these mutants exhibited a specific defect in integration. Mutations at two positions, S-81 and P-109, blocked the integration of viral DNA but also resulted in the production of viral particles that exhibited reduced reverse transcriptase activity, suggesting additional defects in viral replication. Substitution of the highly conserved amino acid T66 had no effect on viral replication in a CD4+ human T-cell line. This analysis extends the range of possible phenotypes that may be produced by single amino acid substitutions in conserved residues of the integrase protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7966634      PMCID: PMC237311          DOI: 10.1128/JVI.68.12.8401-8405.1994

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Analysis of mutations in the integration function of Moloney murine leukemia virus: effects on DNA binding and cutting.

Authors:  M J Roth; P Schwartzberg; N Tanese; S P Goff
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

2.  Retroviral integrase domains: DNA binding and the recognition of LTR sequences.

Authors:  E Khan; J P Mack; R A Katz; J Kulkosky; A M Skalka
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

3.  The trans-activator gene of the human T cell lymphotropic virus type III is required for replication.

Authors:  A I Dayton; J G Sodroski; C A Rosen; W C Goh; W A Haseltine
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

4.  The retrovirus pol gene encodes a product required for DNA integration: identification of a retrovirus int locus.

Authors:  A T Panganiban; H M Temin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

5.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

6.  Genetic evidence that the avian retrovirus DNA endonuclease domain of pol is necessary for viral integration.

Authors:  T P Quinn; D P Grandgenett
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

7.  Genetic recombination of human immunodeficiency virus.

Authors:  F Clavel; M D Hoggan; R L Willey; K Strebel; M A Martin; R Repaske
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

8.  Integration is not necessary for expression of human immunodeficiency virus type 1 protein products.

Authors:  M Stevenson; S Haggerty; C A Lamonica; C M Meier; S K Welch; A J Wasiak
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

9.  Analysis of mutant Moloney murine leukemia viruses containing linker insertion mutations in the 3' region of pol.

Authors:  L A Donehower
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

10.  HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.

Authors:  J A Zack; S J Arrigo; S R Weitsman; A S Go; A Haislip; I S Chen
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

View more
  33 in total

1.  3D-QSAR and molecular modeling of HIV-1 integrase inhibitors.

Authors:  Mahindra T Makhija; Vithal M Kulkarni
Journal:  J Comput Aided Mol Des       Date:  2002-03       Impact factor: 3.686

2.  Correlation of recombinant integrase activity and functional preintegration complex formation during acute infection by replication-defective integrase mutant human immunodeficiency virus.

Authors:  Xiang Li; Yasuhiro Koh; Alan Engelman
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

3.  Interaction between Reverse Transcriptase and Integrase Is Required for Reverse Transcription during HIV-1 Replication.

Authors:  Shewit S Tekeste; Thomas A Wilkinson; Ethan M Weiner; Xiaowen Xu; Jennifer T Miller; Stuart F J Le Grice; Robert T Clubb; Samson A Chow
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

4.  Preliminary mapping of a putative inhibitor-binding pocket for human immunodeficiency virus type 1 integrase inhibitors.

Authors:  Deborah J Lee; W Edward Robinson
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

5.  Analysis of the viral elements required in the nuclear import of HIV-1 DNA.

Authors:  Lise Rivière; Jean-Luc Darlix; Andrea Cimarelli
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

6.  Mutations in nonconserved domains of Ty3 integrase affect multiple stages of the Ty3 life cycle.

Authors:  M H Nymark-McMahon; S B Sandmeyer
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

7.  A chimeric Ty3/Moloney murine leukemia virus integrase protein is active in vivo.

Authors:  S L Dildine; J Respess; D Jolly; S B Sandmeyer
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

8.  Functional interactions of the HHCC domain of moloney murine leukemia virus integrase revealed by nonoverlapping complementation and zinc-dependent dimerization.

Authors:  F Yang; O Leon; N J Greenfield; M J Roth
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1.

Authors:  G Englund; T S Theodore; E O Freed; A Engelman; M A Martin
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

10.  Coordinated disintegration reactions mediated by Moloney murine leukemia virus integrase.

Authors:  G A Donzella; C B Jonsson; M J Roth
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.